Expression of thymidylate synthase in liver and lung metastases of colorectal cancer and their matched primary tumours

Anticancer Research

Volumn 28, Issue 3 B, 2008, Pages 1741-1748

  Katarina, Öhrling ^a   Edler, David ^a   Hallström, Marja ^a   Ragnhammar, Peter ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Colorectal cancer metastases; Matched primary tumours; TS

Indexed keywords

FLUOROURACIL; THYMIDYLATE SYNTHASE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; COLON CANCER; COLORECTAL CANCER; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LUNG METASTASIS; MALE; PREDICTION; PRIORITY JOURNAL; RECTUM CANCER; TREATMENT OUTCOME;

COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; THYMIDYLATE SYNTHASE;

EID: 45949086990     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Weiss L, Grundmann E, Torhost J, Hartveit F, Moberg I, Eder M, Fenoglio-Preiser CM, Napier J, Horne CHW, Lopez MJ, Shaw-Dunn RI, Sugar J, Davies JD, Day DW and Harlos JP: Hematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 150: 195-203, 1996.
2. McCormack PM and Ginsberg RJ: Current management of colorectal metastases to lung. Chest Surg Clin N Am 8(1): 119-126, 1998.
3. Edler D, Hallstrom M, Johnston PG, Magnusson I, Ragnhammar P and Blomgren H: Thymidylate synthase expression: an independent prognostic factor for local recurrence, distant metastasis, disease-free and overall survival in rectal cancer. Clin Cancer Res 6: 1378-1384, 2000.
4. Edler D, Kressner U, Ragnhammar P, Johnston PG, Magnusson I, Glimelius B, Påhlman L, Lindmark G and Blomgren H: Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival. Clin Cancer Res 6: 488-492, 2000.
5. Edler D, Glimelius B, Hallstrom M, Jakobsen A, Johnston PG, Magnusson I, Ragnhammar P and Blomgren H: Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy. J Clin Oncol 20: 1721-1728, 2002.
6. Lenz HJ, Danenberg KD, Leichman CG, Florentine B, Johnston PG, Groshen S, Zhou L, Xiong YP, Danenberg PV and Leichman LP: p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and site. Clin Cancer Res 4: 1227-1234, 1998.
7. Van Triest B, Loftus BM, Pinedo HM, Backus HHJ, Schoenmakers P, Telleman F, Tadema T, Aherne W, Van Groeningen CJ, Zoetmulder FAN, Taal BG, Johnston PG and Peters GJ: Thymidylate synthase expression in patients with colorectal carcinoma using a polyclonal thymidylate synthase antibody in comparison to the TS 106 monoclonal antibody. J Histochem Cytochem 48(6): 755-760, 2000.
8. Allegra CJ, Paik S, Colangelo LH, Parr AL, Kirsch I, Kim G, Klein P, Johnston PG, Wolmark N and Wieand HS: Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study. J Clin Oncol 21(2): 241-250, 2003.
9. Popat S, Matakidou A and Houlston RS: Thymidylate synthase expression and prognosis in colorectal cancer: A systematic review and meta-analysis. J Clin Oncol 22: 529-536, 2004.
10. Leichman L, Lenz HJ and Leicman S: Quantitation of intratumoral thymidylate synthase expression predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers: preliminary report from an ongoing trial. Eur J Cancer 31A(7/8): 1306-1310, 1995.
11. Kamoshida S. Matsuoka H, Ishikawa T, Maeda K, Shimomura R, Inada K and Tsutsumi Y: Immunohistochemical evaluation of thymidylate synthase (TS) and pl6INK4a in advanced colorectal cancer: implication of TS expression in 5-FU based adjuvant chemotherapy. Jpn J Clin Oncol 34(10): 594-601, 2004.
12. Kornmann M, Link KH, Lenz HJ, Pillasch J, Metzger R, Butzer U, Leder GH, Weindel M, Safi F, Danenberg KD, Beger HG and Danenberg PV: Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapy. Cancer Lett 118(1): 29-35, 1997.
13. Aschele C, Debernardis D, Casazza S, Antonelli G, Tunesi G, Baldo C, Lionetto R, Maley F and Sobrero A: Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy. J Clin Oncol 17: 1760-1770, 1999.
14. Johnston PG, Lenz HJ, Leichman CG, Danenberg KD, Allegra CJ, Danenberg PV and Leichman L: Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res 55: 1407-1412, 1995.
15. Lenz HJ, Hayashi K, Salonga D, Danenberg KD, Danenberg PV, Metzger R, Banerjee D, Bertino JR, Groshen S, Leichman LP and Leichman CG: P53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survival. Clin Cancer Res 4: 1243-1250, 1998.
16. Leichman CG, Lenz HJ, Leichman L, Danenberg K, Baranda J, Groshen S, Boswell W, Metzger R, Tan M and Danenberg PV: Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. J Clin Oncol 15: 3223-3229, 1997.
17. Gonen M, Hummer A, Zervoudakis A, Sullivan D, Fong Y, Banerjee D, Klimstra D, Cordon-Cardo C, Bertino J and Kemeny N: Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer. J Clin Oncol 21: 406-412, 2003.
18. Cascinu S, Aschele C, Barni S, Debernardis D, Baldo C, Tunesi G, Catalano V, Staccioli MP, Brenna A, Muretto P and Catalano G: Thymidylate synthase expression in advanced colon cancer. Correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil. Clin Cancer Res 5(8): 1996-1999, 1999.
19. Davies MM, Johnston PG, Kaur S and Allen-Mersh TG: Colorectal liver metastasis thymidylate synthase staining correlates with response to hepatic arterial floxuridine. Clin Cancer Res 5(2): 325-328, 1999.
20. Salonga D, Danenberg KD, Johnson M, Metzger R, Groshen S, Tsao-Wei DD, Lenz HJ, Leichman CG, Leichman L, Diasio RB and Danenberg PV: Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Clin Cancer Res 6(4): 1322-1327, 2000.
21. Libra M, Navolanic PM, Talamini R, Cecchin E, Sartor F, Tumolo S, Masier S, Tavali S, Boiocchi M and Toffoli G: Thymidylate synthetase mRNA levels are increased in liver metastases of colorectal cancer patientes resistant to fluoropyrimidine-based chemotherapy. BMC Cancer 4(1): 11, 2004.
22. Hosokawa A, Yamada Y, Shimada Y, Shimada Y, Muro K, Hamaguchi T, Morita H, Araake M, Orita H and Shirao K: Prognostic significance of thymidylate synthase in patients with metastatic colorectal cancer who receive protracted venous infusions of 5-fluorouracil. Int J Clin Oncol 9(5): 388-392, 2004.
23. Smorenburg CH, Peters GJ, Van Groeningen CJ, Noordhuis P, Smid K, Van Riel AM, Dercksen W, Pinedo HM and Giaccone G: Phase II study of tailored chemotherapy for advanced colorectal cancer with either 5-fluorouracil and leucovorin or oxaliplatin and irinotecan based on the expression of thymidylate synthase and dihydropyrimidene dehydrogenase. Annals of Oncology 17: 35-42, 2006
24. Berglund A, Edler D, Molin D, Nordlinder M, Graf W and Glimelius B: Thymidylate synthase and p53 expression in primary tumor do not predict chmemotherapy outcome in metastatic colorectal cacinoma. Anticancer Res 22: 3653-3660, 2002.
25. Paradiso A, Simone G, Petroni S, Leone B, Vallejo C, Lacava J, Romero A, Machiavelli M, De Lena M, Allegra CJ and Johnston PG: Thymidylate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients. Br J Cancer 82(3): 560-567, 2000.
26. Edler D, Blomgren H, Allegra CJ, Johnston PG, Lagerstedt U, Magnusson I and Ragnhammar P: Immunohistochemical determination of thymidylate synthase in colorectal cancer-methodological studies. Eur J Cancer 33: 2278-2281, 1997.
27. Öhrling K, Edler D, Hallström M, Ragnhammar P and Blomgren H: Detection of thymidylate synthase in lymph node metastases of colorectal cancer can improve the prognostic information. J Clin Oncol 23: 1-7, 2005.
28. Vallböhmer D, Kuramochi H, Shimizu D, Danenberg KD, Linebjerg J, Nielsen JN, Jakobsen A and Danenberg PV: Molecular factors of 5-fluorouracil metabolism in colorectal cancer: analysis of primary tumor and lymph node metastasis. Int J Oncol 28(2): 527-533, 2006.
29. Kuramochi H, Hayashi K, Uchida K, Miyakura S, Shimizu D, Vallbohmer D, Park S, Danenberg KD, Takasaki K and Danenberg PV: 5-fluorouracil-related gene expression levels in primary colorectal cancer and corresponding liver metastasis. Int J Cancer 119(3): 522-526, 2006.
30. Aschele C, Debernardis D, Tunesi G, Maley F and Sobrero A: Thymidylate synthase protein expression in primary colorectal cancer compared with the corresponding distant metastases and relationship with the clinical response to 5-fluorouracil. Clin Cancer Rec 6(12): 4797-4802, 2000.
31. Yamada H, Ichikawa W, Uetake H, Shirota Y, Nihei Z, Sugihara K and Hirayama R: Thymidylate synthase gene expression in primary colorectal cancer and metastatic sites. Clinical Colorectal Cancer 1(3): 169-173, 2001
32. Backus HH, Van Groeningen CJ, Vos W, Dukers DF, Bloemena E, Wouters D, Pinedo HM and Peters GJ: Differential expression of cell cycle and apoptosis related proteins in colorectal mucosa, primary colon tumours, and liver metastases. J Clin Path 55(3): 206-211, 2002.
33. Corsi DC, Ciaparrone M, Zannoni G, Mancini M, Cassano A, Specchia M, Pozzo C, Martini M and Barone C: Predictive value of thymidylate synthase expression in resected metastases of colorectal cancer. Eur J Cancer 38(4): 527-534, 2002.
34. Etienne MC, Chazal M, Laurent-Puig P, Magné N, Rosty C, Formento JL, Francoual M, Formento P, Renée N, Chamorey E, Bourgeon A, Seitz JF, Delpero JR, Letoublon C, Pezet D and Milano G: Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy. J Clin Oncol 20(12): 2832-2843, 2002.
35. Inokuchi M, Uetake H, Shirota Y, Yamada H, Tajima M and Sugihara K: Gene expression of 5-fluorouracil metabolic enzymes in primary colorectal cancer and corresponding livermetastasis. Cancer Chemother Pharmacol 53(5): 391-396, 2004.
36. Bendardaf R, Elzagheid A, Lamlum H, Algars A, Korkeila E, Ristamäki R, Collan Y, Syrjänen K and Pyrhönen S: Thymidylate synthase expression in primary colorectal tumours is correlated with its expression in metastases. Scand J Gastroenterol 42(4): 471-476, 2007.
37. Johnston PG, Liang CM, Henry S, Chabner BA and Allegra C: Production and characterization of monoclonal antibodies that localize human thymidylate synthase in the cytoplasm of human cells and tissue. Cancer Res 51: 6668-6676, 1991.
38. Johnston PG, Fisher ER, Rockette H E, Fisher B, Wolmark N, Drake JC, Chabner BA and Allegra CJ: The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. J Clin Oncol 12: 2640-2647, 1994.
39. Horikoshi T, Danenberg KD, Stadlbauer TH, Volkenandt M, Shea LC, Aigner K, Gustavsson B, Leichman L, Frösing R and Ray M: Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction. Cancer Res 52: 108-116, 1992.
40. Gorlick R, Metzger R, Danenberg KD, Salonga D, Miles JS, Longo GSA, Fu J, Banerjee D, Klimstra D, Jhanwar S, Danenberg PV, Kemeny N and Bertino JR: Higher levels of thymidylate synthase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma: J Clin Oncol 16(4): 1465-1469, 1998.
41. Banerjee D, Gorlick R, Liefshitz A, Danenberg K, Danenberg PC, Danenberg PV, Klimstra D, Jhanwar S, Cordon-Cardo C, Fong Y, Kemeny N and Bertino JR: Levels of E2F-1 expression are higher in lung metastasis of colon cancer as compared with hepatic metastasis and correlate with levels of thymidylate synthase, Cancer Res 60(9): 2365-2367, 2000.
42. Assersohn L, Norman A, Cunningham D, Benepal T, Ross PJ and Oates J: Influence of metastatic site as an additional predictor of response and outcome in advanced colorectal carcinoma. Br J Cancer 79: 1800-1805, 1999.
43. Marsh S, McKay JA, Curran S, Murray GI, Cassidy J and McLeopd HL: Primary colorectal tumour is not an accurate predictor of thymidylate synthase in lymph node metastasis. Oncol Rep 9(2): 231-234, 2002.